Industry Research Reports
Home > Reports > Service & Software > Global Artificial Intelligence in Biomedical Market Research Report 2025
Global Artificial Intelligence in Biomedical Market Research Report 2025
Industry: Service & Software
Published Date: 2025-03-12
Pages: 102 Pages
Report ld: 4647025
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Artificial Intelligence in Biomedical Market Size(US$)
CAGR 2025-2031
30.1%
Market Size,2031
USD 1,215
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 250 million
Market Forecast in 2031(Value)
US$ 1,215 million
CAGR
30.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Artificial Intelligence in Biomedical was valued at US$ 197 million in the year 2024 and is projected to reach a revised size of US$ 1215 million by 2031, growing at a CAGR of 30.1% during the forecast period.
Artificial Intelligence (AI) in biomedical refers to the application of AI technologies, such as machine learning, natural language processing, and computer vision, in the fields of medicine and biology. It is used to analyze complex biomedical data, assist in diagnostics, develop personalized treatment plans, discover new drugs, and improve healthcare outcomes. AI enhances the accuracy, speed, and efficiency of medical and biological research and clinical practices.
North American market for Artificial Intelligence in Biomedical is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Artificial Intelligence in Biomedical is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Artificial Intelligence in Biomedical in Diagnosing Diseases is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Artificial Intelligence in Biomedical include AstraZeneca, Thales Group, IBM Corp., ForeSee Medical, Atomwise, Cloud Pharmaceuticals, GNS Healthcare, Microsoft Corporation, Novartis AG, NVIDIA Corporation, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence in Biomedical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence in Biomedical.
The Artificial Intelligence in Biomedical market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Intelligence in Biomedical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence in Biomedical companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
By Company
- AstraZeneca
- Thales Group
- IBM Corp.
- ForeSee Medical
- Atomwise
- Cloud Pharmaceuticals
- GNS Healthcare
- Microsoft Corporation
- Novartis AG
- NVIDIA Corporation
- Pfizer
- Recursion Pharmaceuticals
- XtalPi Inc
- Aidoc
- AliveCor
- GE Healthcare
- Imagen Technologies
- Vuno Inc.
- IDx Technologies Inc.
- Siemens Healthcare GmbH
- Neural Analytics
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Hardware
- Software
Segment by Application
- Diagnosing Diseases
- Developing Drugs
- Personalized Treatment
- Other
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence in Biomedical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence in Biomedical Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hardware
1.2.3 Software
1.3 Market by Application
1.3.1 Global Artificial Intelligence in Biomedical Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnosing Diseases
1.3.3 Developing Drugs
1.3.4 Personalized Treatment
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence in Biomedical Market Perspective (2020-2031)
2.2 Global Artificial Intelligence in Biomedical Growth Trends by Region
2.2.1 Global Artificial Intelligence in Biomedical Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Artificial Intelligence in Biomedical Historic Market Size by Region (2020-2025)
2.2.3 Artificial Intelligence in Biomedical Forecasted Market Size by Region (2026-2031)
2.3 Artificial Intelligence in Biomedical Market Dynamics
2.3.1 Artificial Intelligence in Biomedical Industry Trends
2.3.2 Artificial Intelligence in Biomedical Market Drivers
2.3.3 Artificial Intelligence in Biomedical Market Challenges
2.3.4 Artificial Intelligence in Biomedical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence in Biomedical Players by Revenue
3.1.1 Global Top Artificial Intelligence in Biomedical Players by Revenue (2020-2025)
3.1.2 Global Artificial Intelligence in Biomedical Revenue Market Share by Players (2020-2025)
3.2 Global Top Artificial Intelligence in Biomedical Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Artificial Intelligence in Biomedical Revenue
3.4 Global Artificial Intelligence in Biomedical Market Concentration Ratio
3.4.1 Global Artificial Intelligence in Biomedical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence in Biomedical Revenue in 2024
3.5 Global Key Players of Artificial Intelligence in Biomedical Head office and Area Served
3.6 Global Key Players of Artificial Intelligence in Biomedical, Product and Application
3.7 Global Key Players of Artificial Intelligence in Biomedical, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence in Biomedical Breakdown Data by Type
4.1 Global Artificial Intelligence in Biomedical Historic Market Size by Type (2020-2025)
4.2 Global Artificial Intelligence in Biomedical Forecasted Market Size by Type (2026-2031)
5 Artificial Intelligence in Biomedical Breakdown Data by Application
5.1 Global Artificial Intelligence in Biomedical Historic Market Size by Application (2020-2025)
5.2 Global Artificial Intelligence in Biomedical Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Artificial Intelligence in Biomedical Market Size (2020-2031)
6.2 North America Artificial Intelligence in Biomedical Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Artificial Intelligence in Biomedical Market Size by Country (2020-2025)
6.4 North America Artificial Intelligence in Biomedical Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence in Biomedical Market Size (2020-2031)
7.2 Europe Artificial Intelligence in Biomedical Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Artificial Intelligence in Biomedical Market Size by Country (2020-2025)
7.4 Europe Artificial Intelligence in Biomedical Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence in Biomedical Market Size (2020-2031)
8.2 Asia-Pacific Artificial Intelligence in Biomedical Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Artificial Intelligence in Biomedical Market Size by Region (2020-2025)
8.4 Asia-Pacific Artificial Intelligence in Biomedical Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence in Biomedical Market Size (2020-2031)
9.2 Latin America Artificial Intelligence in Biomedical Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Artificial Intelligence in Biomedical Market Size by Country (2020-2025)
9.4 Latin America Artificial Intelligence in Biomedical Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence in Biomedical Market Size (2020-2031)
10.2 Middle East & Africa Artificial Intelligence in Biomedical Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (2020-2025)
10.4 Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Artificial Intelligence in Biomedical Introduction
11.1.4 AstraZeneca Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.1.5 AstraZeneca Recent Development
11.2 Thales Group
11.2.1 Thales Group Company Details
11.2.2 Thales Group Business Overview
11.2.3 Thales Group Artificial Intelligence in Biomedical Introduction
11.2.4 Thales Group Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.2.5 Thales Group Recent Development
11.3 IBM Corp.
11.3.1 IBM Corp. Company Details
11.3.2 IBM Corp. Business Overview
11.3.3 IBM Corp. Artificial Intelligence in Biomedical Introduction
11.3.4 IBM Corp. Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.3.5 IBM Corp. Recent Development
11.4 ForeSee Medical
11.4.1 ForeSee Medical Company Details
11.4.2 ForeSee Medical Business Overview
11.4.3 ForeSee Medical Artificial Intelligence in Biomedical Introduction
11.4.4 ForeSee Medical Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.4.5 ForeSee Medical Recent Development
11.5 Atomwise
11.5.1 Atomwise Company Details
11.5.2 Atomwise Business Overview
11.5.3 Atomwise Artificial Intelligence in Biomedical Introduction
11.5.4 Atomwise Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.5.5 Atomwise Recent Development
11.6 Cloud Pharmaceuticals
11.6.1 Cloud Pharmaceuticals Company Details
11.6.2 Cloud Pharmaceuticals Business Overview
11.6.3 Cloud Pharmaceuticals Artificial Intelligence in Biomedical Introduction
11.6.4 Cloud Pharmaceuticals Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.6.5 Cloud Pharmaceuticals Recent Development
11.7 GNS Healthcare
11.7.1 GNS Healthcare Company Details
11.7.2 GNS Healthcare Business Overview
11.7.3 GNS Healthcare Artificial Intelligence in Biomedical Introduction
11.7.4 GNS Healthcare Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.7.5 GNS Healthcare Recent Development
11.8 Microsoft Corporation
11.8.1 Microsoft Corporation Company Details
11.8.2 Microsoft Corporation Business Overview
11.8.3 Microsoft Corporation Artificial Intelligence in Biomedical Introduction
11.8.4 Microsoft Corporation Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.8.5 Microsoft Corporation Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Artificial Intelligence in Biomedical Introduction
11.9.4 Novartis AG Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.9.5 Novartis AG Recent Development
11.10 NVIDIA Corporation
11.10.1 NVIDIA Corporation Company Details
11.10.2 NVIDIA Corporation Business Overview
11.10.3 NVIDIA Corporation Artificial Intelligence in Biomedical Introduction
11.10.4 NVIDIA Corporation Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.10.5 NVIDIA Corporation Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Artificial Intelligence in Biomedical Introduction
11.11.4 Pfizer Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.11.5 Pfizer Recent Development
11.12 Recursion Pharmaceuticals
11.12.1 Recursion Pharmaceuticals Company Details
11.12.2 Recursion Pharmaceuticals Business Overview
11.12.3 Recursion Pharmaceuticals Artificial Intelligence in Biomedical Introduction
11.12.4 Recursion Pharmaceuticals Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.12.5 Recursion Pharmaceuticals Recent Development
11.13 XtalPi Inc
11.13.1 XtalPi Inc Company Details
11.13.2 XtalPi Inc Business Overview
11.13.3 XtalPi Inc Artificial Intelligence in Biomedical Introduction
11.13.4 XtalPi Inc Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.13.5 XtalPi Inc Recent Development
11.14 Aidoc
11.14.1 Aidoc Company Details
11.14.2 Aidoc Business Overview
11.14.3 Aidoc Artificial Intelligence in Biomedical Introduction
11.14.4 Aidoc Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.14.5 Aidoc Recent Development
11.15 AliveCor
11.15.1 AliveCor Company Details
11.15.2 AliveCor Business Overview
11.15.3 AliveCor Artificial Intelligence in Biomedical Introduction
11.15.4 AliveCor Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.15.5 AliveCor Recent Development
11.16 GE Healthcare
11.16.1 GE Healthcare Company Details
11.16.2 GE Healthcare Business Overview
11.16.3 GE Healthcare Artificial Intelligence in Biomedical Introduction
11.16.4 GE Healthcare Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.16.5 GE Healthcare Recent Development
11.17 Imagen Technologies
11.17.1 Imagen Technologies Company Details
11.17.2 Imagen Technologies Business Overview
11.17.3 Imagen Technologies Artificial Intelligence in Biomedical Introduction
11.17.4 Imagen Technologies Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.17.5 Imagen Technologies Recent Development
11.18 Vuno Inc.
11.18.1 Vuno Inc. Company Details
11.18.2 Vuno Inc. Business Overview
11.18.3 Vuno Inc. Artificial Intelligence in Biomedical Introduction
11.18.4 Vuno Inc. Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.18.5 Vuno Inc. Recent Development
11.19 IDx Technologies Inc.
11.19.1 IDx Technologies Inc. Company Details
11.19.2 IDx Technologies Inc. Business Overview
11.19.3 IDx Technologies Inc. Artificial Intelligence in Biomedical Introduction
11.19.4 IDx Technologies Inc. Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.19.5 IDx Technologies Inc. Recent Development
11.20 Siemens Healthcare GmbH
11.20.1 Siemens Healthcare GmbH Company Details
11.20.2 Siemens Healthcare GmbH Business Overview
11.20.3 Siemens Healthcare GmbH Artificial Intelligence in Biomedical Introduction
11.20.4 Siemens Healthcare GmbH Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.20.5 Siemens Healthcare GmbH Recent Development
11.21 Neural Analytics
11.21.1 Neural Analytics Company Details
11.21.2 Neural Analytics Business Overview
11.21.3 Neural Analytics Artificial Intelligence in Biomedical Introduction
11.21.4 Neural Analytics Revenue in Artificial Intelligence in Biomedical Business (2020-2025)
11.21.5 Neural Analytics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Artificial Intelligence in Biomedical Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Hardware
Table 3. Key Players of Software
Table 4. Global Artificial Intelligence in Biomedical Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Artificial Intelligence in Biomedical Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Artificial Intelligence in Biomedical Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Artificial Intelligence in Biomedical Market Share by Region (2020-2025)
Table 8. Global Artificial Intelligence in Biomedical Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Artificial Intelligence in Biomedical Market Share by Region (2026-2031)
Table 10. Artificial Intelligence in Biomedical Market Trends
Table 11. Artificial Intelligence in Biomedical Market Drivers
Table 12. Artificial Intelligence in Biomedical Market Challenges
Table 13. Artificial Intelligence in Biomedical Market Restraints
Table 14. Global Artificial Intelligence in Biomedical Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Artificial Intelligence in Biomedical Market Share by Players (2020-2025)
Table 16. Global Top Artificial Intelligence in Biomedical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence in Biomedical as of 2024)
Table 17. Ranking of Global Top Artificial Intelligence in Biomedical Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Artificial Intelligence in Biomedical Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Artificial Intelligence in Biomedical, Headquarters and Area Served
Table 20. Global Key Players of Artificial Intelligence in Biomedical, Product and Application
Table 21. Global Key Players of Artificial Intelligence in Biomedical, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Artificial Intelligence in Biomedical Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Artificial Intelligence in Biomedical Revenue Market Share by Type (2020-2025)
Table 25. Global Artificial Intelligence in Biomedical Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Artificial Intelligence in Biomedical Revenue Market Share by Type (2026-2031)
Table 27. Global Artificial Intelligence in Biomedical Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Artificial Intelligence in Biomedical Revenue Market Share by Application (2020-2025)
Table 29. Global Artificial Intelligence in Biomedical Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Artificial Intelligence in Biomedical Revenue Market Share by Application (2026-2031)
Table 31. North America Artificial Intelligence in Biomedical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Artificial Intelligence in Biomedical Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Artificial Intelligence in Biomedical Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Artificial Intelligence in Biomedical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Artificial Intelligence in Biomedical Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Artificial Intelligence in Biomedical Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Artificial Intelligence in Biomedical Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Artificial Intelligence in Biomedical Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Artificial Intelligence in Biomedical Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Artificial Intelligence in Biomedical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Artificial Intelligence in Biomedical Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Artificial Intelligence in Biomedical Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Artificial Intelligence in Biomedical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (2026-2031) & (US$ Million)
Table 46. AstraZeneca Company Details
Table 47. AstraZeneca Business Overview
Table 48. AstraZeneca Artificial Intelligence in Biomedical Product
Table 49. AstraZeneca Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 50. AstraZeneca Recent Development
Table 51. Thales Group Company Details
Table 52. Thales Group Business Overview
Table 53. Thales Group Artificial Intelligence in Biomedical Product
Table 54. Thales Group Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 55. Thales Group Recent Development
Table 56. IBM Corp. Company Details
Table 57. IBM Corp. Business Overview
Table 58. IBM Corp. Artificial Intelligence in Biomedical Product
Table 59. IBM Corp. Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 60. IBM Corp. Recent Development
Table 61. ForeSee Medical Company Details
Table 62. ForeSee Medical Business Overview
Table 63. ForeSee Medical Artificial Intelligence in Biomedical Product
Table 64. ForeSee Medical Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 65. ForeSee Medical Recent Development
Table 66. Atomwise Company Details
Table 67. Atomwise Business Overview
Table 68. Atomwise Artificial Intelligence in Biomedical Product
Table 69. Atomwise Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 70. Atomwise Recent Development
Table 71. Cloud Pharmaceuticals Company Details
Table 72. Cloud Pharmaceuticals Business Overview
Table 73. Cloud Pharmaceuticals Artificial Intelligence in Biomedical Product
Table 74. Cloud Pharmaceuticals Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 75. Cloud Pharmaceuticals Recent Development
Table 76. GNS Healthcare Company Details
Table 77. GNS Healthcare Business Overview
Table 78. GNS Healthcare Artificial Intelligence in Biomedical Product
Table 79. GNS Healthcare Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 80. GNS Healthcare Recent Development
Table 81. Microsoft Corporation Company Details
Table 82. Microsoft Corporation Business Overview
Table 83. Microsoft Corporation Artificial Intelligence in Biomedical Product
Table 84. Microsoft Corporation Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 85. Microsoft Corporation Recent Development
Table 86. Novartis AG Company Details
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Artificial Intelligence in Biomedical Product
Table 89. Novartis AG Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 90. Novartis AG Recent Development
Table 91. NVIDIA Corporation Company Details
Table 92. NVIDIA Corporation Business Overview
Table 93. NVIDIA Corporation Artificial Intelligence in Biomedical Product
Table 94. NVIDIA Corporation Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 95. NVIDIA Corporation Recent Development
Table 96. Pfizer Company Details
Table 97. Pfizer Business Overview
Table 98. Pfizer Artificial Intelligence in Biomedical Product
Table 99. Pfizer Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 100. Pfizer Recent Development
Table 101. Recursion Pharmaceuticals Company Details
Table 102. Recursion Pharmaceuticals Business Overview
Table 103. Recursion Pharmaceuticals Artificial Intelligence in Biomedical Product
Table 104. Recursion Pharmaceuticals Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 105. Recursion Pharmaceuticals Recent Development
Table 106. XtalPi Inc Company Details
Table 107. XtalPi Inc Business Overview
Table 108. XtalPi Inc Artificial Intelligence in Biomedical Product
Table 109. XtalPi Inc Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 110. XtalPi Inc Recent Development
Table 111. Aidoc Company Details
Table 112. Aidoc Business Overview
Table 113. Aidoc Artificial Intelligence in Biomedical Product
Table 114. Aidoc Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 115. Aidoc Recent Development
Table 116. AliveCor Company Details
Table 117. AliveCor Business Overview
Table 118. AliveCor Artificial Intelligence in Biomedical Product
Table 119. AliveCor Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 120. AliveCor Recent Development
Table 121. GE Healthcare Company Details
Table 122. GE Healthcare Business Overview
Table 123. GE Healthcare Artificial Intelligence in Biomedical Product
Table 124. GE Healthcare Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 125. GE Healthcare Recent Development
Table 126. Imagen Technologies Company Details
Table 127. Imagen Technologies Business Overview
Table 128. Imagen Technologies Artificial Intelligence in Biomedical Product
Table 129. Imagen Technologies Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 130. Imagen Technologies Recent Development
Table 131. Vuno Inc. Company Details
Table 132. Vuno Inc. Business Overview
Table 133. Vuno Inc. Artificial Intelligence in Biomedical Product
Table 134. Vuno Inc. Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 135. Vuno Inc. Recent Development
Table 136. IDx Technologies Inc. Company Details
Table 137. IDx Technologies Inc. Business Overview
Table 138. IDx Technologies Inc. Artificial Intelligence in Biomedical Product
Table 139. IDx Technologies Inc. Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 140. IDx Technologies Inc. Recent Development
Table 141. Siemens Healthcare GmbH Company Details
Table 142. Siemens Healthcare GmbH Business Overview
Table 143. Siemens Healthcare GmbH Artificial Intelligence in Biomedical Product
Table 144. Siemens Healthcare GmbH Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 145. Siemens Healthcare GmbH Recent Development
Table 146. Neural Analytics Company Details
Table 147. Neural Analytics Business Overview
Table 148. Neural Analytics Artificial Intelligence in Biomedical Product
Table 149. Neural Analytics Revenue in Artificial Intelligence in Biomedical Business (2020-2025) & (US$ Million)
Table 150. Neural Analytics Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 154. Authors List of This Report
List of Figures
Figure 1. Artificial Intelligence in Biomedical Picture
Figure 2. Global Artificial Intelligence in Biomedical Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Artificial Intelligence in Biomedical Market Share by Type: 2024 VS 2031
Figure 4. Hardware Features
Figure 5. Software Features
Figure 6. Global Artificial Intelligence in Biomedical Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Artificial Intelligence in Biomedical Market Share by Application: 2024 VS 2031
Figure 8. Diagnosing Diseases Case Studies
Figure 9. Developing Drugs Case Studies
Figure 10. Personalized Treatment Case Studies
Figure 11. Other Case Studies
Figure 12. Artificial Intelligence in Biomedical Report Years Considered
Figure 13. Global Artificial Intelligence in Biomedical Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Artificial Intelligence in Biomedical Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Artificial Intelligence in Biomedical Market Share by Region: 2024 VS 2031
Figure 16. Global Artificial Intelligence in Biomedical Market Share by Players in 2024
Figure 17. Global Artificial Intelligence in Biomedical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Artificial Intelligence in Biomedical Revenue in 2024
Figure 19. North America Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Artificial Intelligence in Biomedical Market Share by Country (2020-2031)
Figure 21. United States Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Artificial Intelligence in Biomedical Market Share by Country (2020-2031)
Figure 25. Germany Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Artificial Intelligence in Biomedical Market Share by Region (2020-2031)
Figure 33. China Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Artificial Intelligence in Biomedical Market Share by Country (2020-2031)
Figure 41. Mexico Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Artificial Intelligence in Biomedical Market Share by Country (2020-2031)
Figure 45. Turkey Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Artificial Intelligence in Biomedical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. AstraZeneca Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 49. Thales Group Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 50. IBM Corp. Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 51. ForeSee Medical Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 52. Atomwise Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 53. Cloud Pharmaceuticals Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 54. GNS Healthcare Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 55. Microsoft Corporation Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 56. Novartis AG Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 57. NVIDIA Corporation Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 58. Pfizer Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 59. Recursion Pharmaceuticals Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 60. XtalPi Inc Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 61. Aidoc Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 62. AliveCor Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 63. GE Healthcare Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 64. Imagen Technologies Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 65. Vuno Inc. Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 66. IDx Technologies Inc. Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 67. Siemens Healthcare GmbH Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 68. Neural Analytics Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Artificial Intelligence in Biomedical in 2025?
The global market size of Artificial Intelligence in Biomedical in 2025 was 250 Million USD.
Which companies rank high in the global Artificial Intelligence in Biomedical market?
What is the annual compound growth rate of the global Artificial Intelligence in Biomedical market size from 2025 to 2031?
What was the global market size of Artificial Intelligence in Biomedical in 2031?
Which region is expected to have the highest market share?
Related Reports
Global Artificial Intelligence in Biomedical Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Artificial Intelligence in Biomedical market is projected to grow from US$ 250 million in 2025 to US$ 1545 million by 2032, at a CAGR of 30.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-24
Pages: 175
USD 4900.00
(Single User License)
Global Artificial Intelligence in Biomedical Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Artificial Intelligence in Biomedical market size was US$ 250 million in 2025 and is forecast to reach a readjusted size of US$ 1545 million by 2032 with a CAGR of 30.1% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 118
USD 4250.00
(Single User License)
Artificial Intelligence in Biomedical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Artificial Intelligence in Biomedical was estimated to be worth US$ 250 million in 2025 and is projected to reach US$ 1545 million, growing at a CAGR of 30.1% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 143
USD 3950.00
(Single User License)
Global Artificial Intelligence in Biomedical Market Research Report 2026
The global Artificial Intelligence in Biomedical market was valued at US$ 250 million in 2025 and is anticipated to reach US$ 1545 million by 2032, at a CAGR of 30.1% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 160
USD 2900.00
(Single User License)
Global Artificial Intelligence in Biomedical Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Artificial Intelligence in Biomedical market size was US$ 197 million in 2024 and is forecast to a readjusted size of US$ 1215 million by 2031 with a CAGR of 30.1% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 111
USD 4250.00
(Single User License)
Global Artificial Intelligence in Biomedical Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Artificial Intelligence in Biomedical market is projected to grow from US$ 197 million in 2024 to US$ 1215 million by 2031, at a CAGR of 30.1% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 165
USD 4900.00
(Single User License)
Artificial Intelligence in Biomedical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Artificial Intelligence in Biomedical was estimated to be worth US$ 197 million in 2024 and is forecast to a readjusted size of US$ 1215 million by 2031 with a CAGR of 30.1% during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 146
USD 3950.00
(Single User License)
Global and United States Artificial Intelligence in Biomedical Market Report & Forecast 2024-2030
The global Artificial Intelligence in Biomedical revenue was US$ 150 million in 2023 and is forecast to a readjusted size of US$ 956 million by 2030 with a CAGR of 30.1% during the review period (2024-2030).
Published Date: 2024-12-28
Pages: 147
USD 4350.00
(Single User License)
Global Artificial Intelligence in Biomedical Market Insights, Forecast to 2030
Valued at US$ 197 million in 2024, the global Artificial Intelligence in Biomedical market is forecast to reach US$ 956 million by 2030, at a CAGR of 30.1% during the forecast period.
Published Date: 2024-12-28
Pages: 167
USD 4900.00
(Single User License)
Artificial Intelligence in Biomedical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Artificial Intelligence in Biomedical was estimated to be worth US$ 150 million in 2023 and is forecast to a readjusted size of US$ 956 million by 2030 with a CAGR of 30.1% during the forecast period 2024-2030.
Published Date: 2024-12-28
Pages: 141
USD 3950.00
(Single User License)
Global Artificial Intelligence in Biomedical Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Artificial Intelligence in Biomedical market is projected to grow from US$ 250 million in 2025 to US$ 1545 million by 2032, at a CAGR of 30.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-24
Pages: 175
USD 4900.00 (Single User License)Global Artificial Intelligence in Biomedical Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Artificial Intelligence in Biomedical market size was US$ 250 million in 2025 and is forecast to reach a readjusted size of US$ 1545 million by 2032 with a CAGR of 30.1% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 118
USD 4250.00 (Single User License)Artificial Intelligence in Biomedical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Artificial Intelligence in Biomedical was estimated to be worth US$ 250 million in 2025 and is projected to reach US$ 1545 million, growing at a CAGR of 30.1% from 2026 to 2032.
Published: 2026-01-19
Pages: 143
USD 3950.00 (Single User License)Global Artificial Intelligence in Biomedical Market Research Report 2026
The global Artificial Intelligence in Biomedical market was valued at US$ 250 million in 2025 and is anticipated to reach US$ 1545 million by 2032, at a CAGR of 30.1% from 2026 to 2032.
Published: 2026-01-08
Pages: 160
USD 2900.00 (Single User License)Global Artificial Intelligence in Biomedical Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Artificial Intelligence in Biomedical market size was US$ 197 million in 2024 and is forecast to a readjusted size of US$ 1215 million by 2031 with a CAGR of 30.1% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 111
USD 4250.00 (Single User License)Global Artificial Intelligence in Biomedical Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Artificial Intelligence in Biomedical market is projected to grow from US$ 197 million in 2024 to US$ 1215 million by 2031, at a CAGR of 30.1% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 165
USD 4900.00 (Single User License)Artificial Intelligence in Biomedical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Artificial Intelligence in Biomedical was estimated to be worth US$ 197 million in 2024 and is forecast to a readjusted size of US$ 1215 million by 2031 with a CAGR of 30.1% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 146
USD 3950.00 (Single User License)Global and United States Artificial Intelligence in Biomedical Market Report & Forecast 2024-2030
The global Artificial Intelligence in Biomedical revenue was US$ 150 million in 2023 and is forecast to a readjusted size of US$ 956 million by 2030 with a CAGR of 30.1% during the review period (2024-2030).
Published: 2024-12-28
Pages: 147
USD 4350.00 (Single User License)Global Artificial Intelligence in Biomedical Market Insights, Forecast to 2030
Valued at US$ 197 million in 2024, the global Artificial Intelligence in Biomedical market is forecast to reach US$ 956 million by 2030, at a CAGR of 30.1% during the forecast period.
Published: 2024-12-28
Pages: 167
USD 4900.00 (Single User License)Artificial Intelligence in Biomedical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Artificial Intelligence in Biomedical was estimated to be worth US$ 150 million in 2023 and is forecast to a readjusted size of US$ 956 million by 2030 with a CAGR of 30.1% during the forecast period 2024-2030.
Published: 2024-12-28
Pages: 141
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now